These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2783015)

  • 1. [Biotransformation of benzamidine and benzamidoxime by microsomal enzymes of the rabbit].
    Clement B; Zimmermann M; Schmitt S
    Arch Pharm (Weinheim); 1989 Jul; 322(7):431-5. PubMed ID: 2783015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the microsomal N-hydroxylation of benzamidine to benzamidoxime.
    Clement B; Zimmermann M
    Xenobiotica; 1987 Jun; 17(6):659-67. PubMed ID: 3630202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microsomal N-demethylation of N-methylbenzamidine. N-dealkylation vs N-oxygenation of amidines.
    Clement B; Zimmermann M
    Biochem Pharmacol; 1987 Oct; 36(19):3127-33. PubMed ID: 3663229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-hydroxylation and N-dealkylation by P4502C3 of N-methylbenzamidine: N-oxygenation and N-oxidative dealkylation of one functional group.
    Clement B; Jung F
    Xenobiotica; 1995 May; 25(5):443-55. PubMed ID: 7571718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-hydroxylation of benzamidine to benzamidoxime by a reconstituted cytochrome P-450 oxidase system from rabbit liver: involvement of cytochrome P-450 IIC3.
    Clement B; Jung F; Pfunder H
    Mol Pharmacol; 1993 Mar; 43(3):335-42. PubMed ID: 8450831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of benzamidine and benzamidoxime in vivo.
    Clement B; Immel M; Schmitt S; Steinmann U
    Arch Pharm (Weinheim); 1993 Oct; 326(10):807-12. PubMed ID: 8267515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxic activities of benzamidine and its N-hydroxylated metabolite benzamidoxime in Salmonella typhimurium and mammalian cells.
    Clement B; Schmezer P; Weber H; Schlehofer JR; Schmitt S; Pool BL
    J Cancer Res Clin Oncol; 1988; 114(4):363-8. PubMed ID: 3045129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of amphetamine hydroxylamine and other aliphatic hydroxylamines by benzamidoxime reductase and human liver microsomes.
    Clement B; Behrens D; Möller W; Cashman JR
    Chem Res Toxicol; 2000 Oct; 13(10):1037-45. PubMed ID: 11080052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid).
    Clement B; Mau S; Deters S; Havemeyer A
    Drug Metab Dispos; 2005 Nov; 33(11):1740-7. PubMed ID: 16118330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 2 metabolites of N-hydroxylated amidines (amidoximes): synthesis, in vitro formation by pig hepatocytes, and mutagenicity testing.
    Clement B; Christiansen K; Girreser U
    Chem Res Toxicol; 2001 Mar; 14(3):319-26. PubMed ID: 11258982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-oxidation of benzamidines in vitro.
    Clement B
    Xenobiotica; 1983 Aug; 13(8):467-73. PubMed ID: 6649680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2.
    Clement B; Demesmaeker M
    Drug Metab Dispos; 1997 Nov; 25(11):1266-71. PubMed ID: 9351903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The in vitro N-oxygenation of N-tert.alkyl-substituted benzamidine].
    Clement B; Immel M
    Arch Pharm (Weinheim); 1987 Jul; 320(7):660-5. PubMed ID: 3675161
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of benzamidoxime (N-hydroxyamidine) in human hepatocytes and role of UDP-glucuronosyltransferases.
    Fröhlich AK; Girreser U; Clement B
    Xenobiotica; 2005 Jan; 35(1):17-25. PubMed ID: 15788365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic reduction of benzamidoxime to benzamidine.
    Clement B; Schmitt S; Zimmermann M
    Arch Pharm (Weinheim); 1988 Dec; 321(12):955-6. PubMed ID: 3245766
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of the microsomal N-hydroxylation of para-substituted benzamidines.
    Clement B; Zimmermann M
    Biochem Pharmacol; 1988 Dec; 37(24):4747-52. PubMed ID: 3202907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the biological oxidation of arginine to NG-hydroxyarginine, citrulline, and nitric oxide.
    Clement B; Jung F
    Drug Metab Dispos; 1994; 22(3):486-97. PubMed ID: 8070328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and partial purification of the rat and human enzyme systems active in the reduction of N-hydroxymelagatran and benzamidoxime.
    Andersson S; Hofmann Y; Nordling A; Li XQ; Nivelius S; Andersson TB; Ingelman-Sundberg M; Johansson I
    Drug Metab Dispos; 2005 Apr; 33(4):570-8. PubMed ID: 15640373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of amiodarone by rabbit and rat liver and small intestine.
    Young RA; Mehendale HM
    Drug Metab Dispos; 1986; 14(4):423-9. PubMed ID: 2873989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: characterization of the two reactions and genotoxic potential of guanoxabenz.
    Clement B; Demesmaeker M; Linne S
    Chem Res Toxicol; 1996 Jun; 9(4):682-8. PubMed ID: 8831810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.